We have qualitatively reviewed American Century Mid Cap Value and reaffirmed its Process and People ratings. The team’s strong leader and process remain in place, and his team has been steady. One-year returns (through Sept. 30, 2023), while disappointing, have not been out of character, as growth gains left this defensive strategy out of favor. The following text is from Oct. 31, 2022.
American Century Mid Cap Value R AMVRX
- NAV / 1-Day Return 16.12 / +0.50 %
- Total Assets 8.9 Bil
-
Adj. Expense Ratio
- Expense Ratio 1.480%
- Distribution Fee Level High
- Share Class Type Retirement, Medium
- Category Mid-Cap Value
- Investment Style Mid Value
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 1.20%
- Turnover 64%
USD | NAV as of Mar 28, 2024 | 1-Day Return as of Mar 28, 2024, 10:12 PM GMT+0
Morningstar’s Analysis AMVRX
Will AMVRX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 22.0
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Zimmer Biomet Holdings Inc | 3.10 | 276.0 Mil | Healthcare |
Conagra Brands Inc | 2.44 | 217.3 Mil | Consumer Defensive |
Allstate Corp | 2.28 | 202.7 Mil | Financial Services |
Henry Schein Inc | 2.27 | 202.1 Mil | Healthcare |
Bank of New York Mellon Corp | 2.20 | 195.7 Mil | Financial Services |
Northern Trust Corp | 2.16 | 191.9 Mil | Financial Services |
Quest Diagnostics Inc | 1.93 | 171.3 Mil | Healthcare |
Enterprise Products Partners LP | 1.88 | 167.2 Mil | Energy |
Koninklijke Ahold Delhaize NV | 1.86 | 165.1 Mil | Consumer Defensive |
Norfolk Southern Corp | 1.83 | 162.4 Mil | Industrials |